These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7752477)

  • 1. [Bone histomorphometric analysis in primary hyperparathyroidism].
    Kinto N; Tanizawa T; Takahashi HE
    Nihon Rinsho; 1995 Apr; 53(4):879-84. PubMed ID: 7752477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperparathyroidism: lessons from bone histomorphometry.
    Eriksen EF
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N95-7. PubMed ID: 12412784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment.
    Steiniche T; Christiansen P; Vesterby A; Ullerup R; Hessov I; Mosekilde LE; Melsen F
    Bone; 2000 May; 26(5):535-43. PubMed ID: 10773596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphology in primary hyperparathyroidism--a qualitative and quantitative study of 391 cases.
    Delling G
    Appl Pathol; 1987; 5(3):147-59. PubMed ID: 3620210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods.
    Christiansen P; Steiniche T; Vesterby A; Mosekilde L; Hessov I; Melsen F
    Bone; 1992; 13(1):41-9. PubMed ID: 1581108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimodeling reduces the rate of cortical bone loss in patients with secondary hyperparathyroidism.
    Yajima A; Inaba M; Tominaga Y; Ito A
    Am J Kidney Dis; 2007 Mar; 49(3):440-51. PubMed ID: 17336706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
    Seeman E
    Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone histomorphometry and serum concentrations of intact parathyroid hormone (PTH(1-84)) in patients with primary hyperparathyroidism.
    van Doorn L; Lips P; Netelenbos JC; Hackeng WH
    Bone Miner; 1993 Dec; 23(3):233-42. PubMed ID: 8148668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.
    Boyce RW; Paddock CL; Franks AF; Jankowsky ML; Eriksen EF
    J Bone Miner Res; 1996 May; 11(5):600-13. PubMed ID: 9157775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism.
    Dempster DW; Parisien M; Silverberg SJ; Liang XG; Schnitzer M; Shen V; Shane E; Kimmel DB; Recker R; Lindsay R; Bilezikian JP
    J Clin Endocrinol Metab; 1999 May; 84(5):1562-6. PubMed ID: 10323380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry.
    Parfitt AM
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):387-403. PubMed ID: 12815335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers.
    Hauge EM; Qvesel D; Eriksen EF; Mosekilde L; Melsen F
    J Bone Miner Res; 2001 Sep; 16(9):1575-82. PubMed ID: 11547826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.
    Eriksen EF; Charles P; Melsen F; Mosekilde L; Risteli L; Risteli J
    J Bone Miner Res; 1993 Feb; 8(2):127-32. PubMed ID: 8442431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphometric evaluation of osteoclasts in non-decalcified bone sections. Its value in the diagnosis of hyperparathyroidism].
    Jacob B; Borel B; Rousselot P; Mandard JC
    Ann Anat Pathol (Paris); 1979; 24(1):87-95. PubMed ID: 496082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary hyperparathyroidism and the skeleton.
    Mosekilde L
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
    Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
    Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
    Compston JE
    Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The morphological changes in trabecular architecture of bone in severe primary hyperparathyroidism].
    Qiu MC; Li YK; Liu WB
    Zhonghua Wai Ke Za Zhi; 1994 Oct; 32(10):626-8. PubMed ID: 7750425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of intermittent administration of human PTH on experimental osteopenia in adult rat: a histomorphometric study of both trabecular and cortical bone of the vertebrae].
    Narita Y
    Nihon Seikeigeka Gakkai Zasshi; 1995 Oct; 69(10):1027-36. PubMed ID: 8551088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.